While short-lived interferon responses due to acute STING stimulation have clear anti-tumour effects mediated by IFN-Is, it has been shown that low levels of chronic IFN-β signalling can promote cancer cell survival (Figure 3B) [125–128]. The gene discussed is IFNB1; the disease is neoplasm.